Autologous Transplantation of P63+Lung Progenitor Cells for Chronic Obstructive Pulmonary Disease Therapy: An Open-label, Controlled, First-in-Human Trial

被引：0
|
作者：
Zhang, T. [1 ]
Wang, Y. [2 ]
Zhou, Y. [1 ]
Zhao, Y. [2 ]
Zuo, W. [2 ]
机构：
[1] Regend Therapeut, Shanghai, Peoples R China
[2] Tongji Univ, Stem Cell Ctr, Shanghai, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1221
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparison of the efficacy and tolerability of mepifylline oral solution versus inhaled ipratropium bromide in patients with stable chronic obstructive pulmonary disease: A randomized, active-controlled, open-label study
    Sampablo, I
    Sueiro, A
    Burgos, A
    Moreno, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (02): : 110 - 127
  • [32] Dynamic chest radiographic evaluation of the effects of tiotropium/olodaterol combination therapy in chronic obstructive pulmonary disease: the EMBODY study protocol for an open-label, prospective, single-centre, non-controlled, comparative study
    Ikari, Jun
    Katsumata, Megumi
    Urano, Akira
    Imamoto, Takuro
    Suzuki, Yuri
    Nishiyama, Akira
    Yokota, Hajime
    Ono, Kojiro
    Okamoto, Kentaro
    Abe, Eriko
    Kamata, Tomoko
    Fujii, Shota
    Okumura, Kenichiro
    Ota, Joji
    Suzuki, Eiko
    Kawata, Naoko
    Ozawa, Yoshihito
    Masuda, Yoshitada
    Matsushita, Kazuyuki
    Sakao, Seiichiro
    Uno, Takashi
    Tatsumi, Koichiro
    Suzuki, Takuji
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01) : 1 - 7
  • [33] SAFETY AND EFFICACY OF INTRA-RENAL ARTERIAL AUTOLOGOUS CD34+CELL TRANSFUSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A RANDOMIZED, OPEN-LABEL, CONTROLLED PHASE II CLINICAL TRIAL
    Yang, Chihchao
    Li, Yi-Chen
    Yip, Honkan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 484 - 484
  • [34] Comparison of Immediate and Sequential Withdrawal of a Systemic Glucocorticoid in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Parallel-Controlled, Open-Label Study
    Zhou, Ling
    Fang, Yuanyuan
    Liu, Wei
    Zhang, Jianchu
    Wang, Yingnan
    Xie, Sheng
    Zhong, Minhua
    Wang, Zhengyan
    Li, Guangcai
    Ai, Hongyan
    Guo, Hongrong
    Zeng, Fanjun
    Xiao, Wei
    Li, Chenghong
    Hu, Yi
    Tang, Yijun
    Liu, Huiguo
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [35] A phase Ia/Ib, open-label first-in-human study of the safety, tolerability, and feasibility of gene-edited autologous NeoTCR-T cells (NeoTCR-P1) administered to patients with locally advanced or metastatic solid tumors.
    Chmielowski, Bartosz
    Ejadi, Samuel
    Funke, Roel
    Stalligs-Schmitt, Todd
    Denker, Mitch
    Frohlich, Mark Walter
    Franzusoff, Alexis J.
    Abedi, Mehrdad
    Cristea, Mihaela C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial
    Yildiz, Pinar
    Bayraktaroglu, Mesut
    Gorgun, Didem
    Secik, Funda
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 2859 - 2867
  • [37] Evaluation of the Effectiveness of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Chronic Low Back Pain Due to Severe Lumbar Spinal Degeneration: A 12-Month, Open-Label, Prospective Controlled Trial
    Atluri, Sairam
    Murphy, Matthew B.
    Dragella, Ryan
    Herrera, Jessica
    Boachie-Adjei, Kwadwo
    Bhati, Sachi
    Manocha, Vivek
    Boddu, Navneet
    Yerramsetty, Pavan
    Syed, Zaid
    Ganjam, Meghana
    Jain, Divit
    Syed, Zaynab
    Grandhi, Nikhil
    Manchikanti, Laxmaiah
    PAIN PHYSICIAN, 2022, 25 (02) : 193 - 207
  • [38] Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients:: A prospective, randomized, controlled, open-label trial.
    Gerna, G
    Baldanti, F
    Lilleri, D
    Parea, M
    Torsellini, M
    Castiglioni, B
    Vitulo, P
    Pellegrini, C
    Viganò, M
    Grossi, P
    Revello, MG
    TRANSPLANTATION, 2003, 75 (07) : 1012 - 1019
  • [39] BKT140 Is a Novel CXCR4 Antagonist with Stem Cell Mobilization and Antimyeloma Effects: An Open-Label First Human Trial In Patients with Multiple Myeloma Undergoing Stem Cell Mobilization for Autologous Transplantation.
    Nagler, Arnon
    Shimoni, Avichai
    Avivi, Irit
    Rowe, Jacob M.
    Beider, Katia
    Hardan, Izhar
    Abraham, Michal
    Wald, Hanna
    Galun, Eithan
    Shaw, Howard Laurence
    Eizenberg, Orly
    Peled, Amnon
    BLOOD, 2010, 116 (21) : 929 - 930
  • [40] PRELIMINARY EVALUATION OF THE SAFETY AND ANALGESIC EFFECT OF THE TRPV1 AGONIST RTX-GRT7039-AN OPEN-LABEL, FIRST-IN-HUMAN STUDY IN PATIENTS WITH CHRONIC PAIN DUE TO KNEE OSTEOARTHRITIS (STUDY P01)
    Ostenfeld, Thor
    Young, Nicola
    Eibl, Christoph
    Ivanavicius, Stefan
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S212 - S213
12345